Keyphrases
Experimental Therapeutics
66%
Preclinical Development
66%
Resource Sharing
44%
Drug Development
44%
Clinical Evaluation
44%
Robust Capability
33%
Agent Design
33%
Immune Checkpoint Inhibitors
33%
Fragment Screening
33%
Recognition Peptide
33%
Bax inhibitor-1
33%
Chemical Library Screening
33%
Rational Agents
33%
Novel Protein
22%
Bioinformatics
22%
X-ray Crystallography
22%
Inhibitory Antibody
22%
Immune Monitoring
22%
Therapeutic Program
22%
Therapeutic Development
22%
T Cells
22%
T-cell Leukemia
22%
NMR Spectrometry
22%
Mouse Xenograft
22%
Human Cancer
22%
Japan
22%
Immune System
22%
Pharma
22%
Tumor Escape
22%
Translational Studies
22%
Clinical Treatment
22%
Development Effort
22%
Immune Checkpoint
22%
Cardiotoxicity
22%
Design Development
22%
Mass Spectrometry
22%
Immunotherapeutics
22%
Computational Biology
22%
Antineoplastic Agents
22%
Cell Apoptosis
22%
Laboratory Scientists
22%
Systems Biology
22%
Clinically Significant
22%
T Cell Clone
22%
Investigator-initiated Studies
22%
Cell Signaling
22%
Protein Production
22%
Small Molecule Activation
22%
Cancer Treatment
22%
Targeted Agents
22%
Epigenetic Mechanisms
22%
Transition State Inhibitors
22%
T Cell Repertoire
22%
Novel Family
22%
Small Molecule Screening
22%
Small Fragments
22%
Chemical Synthesis
22%
Minimal Impact
22%
Novel Agents
22%
Therapeutic Trial
22%
Drug Design
22%
Co-inhibitory Molecules
22%
Transition State
22%
Cytotoxic Agents
22%
Leukemia-lymphoma
22%
Medicine and Dentistry
Experimental Therapeutic
66%
T Cell
66%
Clinical Trial
44%
Immune Checkpoint Inhibitor
33%
Cancer Cell
22%
Xenograft
22%
Cardiotoxicity
22%
Programmed Cell Death
22%
Electrocorticography
22%
Chimeric Antigen Receptor T-Cell Therapy
22%
Disease
22%
Tumor Escape
22%
Mass Spectrum
22%
Malignant Neoplasm
22%
In Vitro
22%
Combination Therapy
22%
Side Effect
22%
Nuclear Magnetic Resonance Spectroscopy
22%
Anticarcinogen
22%
Immune System
22%
Adult T-Cell Leukemia/Lymphoma
22%
Cancer Treatment
22%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Preclinical Study
75%
Clinical Trial
50%
Small Molecule
50%
Immune Checkpoints
50%
Mouse
25%
Monospecific Antibody
25%
Epigenetics
25%
Synthesis
25%
Electrocorticography
25%
Tumor Escape
25%
Cancer Cell
25%
Crystallography
25%
Mass Spectrometry
25%
Cell Clone
25%